nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—CYP3A4—Topotecan—lung cancer	0.052	0.142	CbGbCtD
Solifenacin—CYP3A4—Gefitinib—lung cancer	0.0476	0.13	CbGbCtD
Solifenacin—CYP3A4—Teniposide—lung cancer	0.0461	0.126	CbGbCtD
Solifenacin—CYP3A4—Vinorelbine—lung cancer	0.0367	0.1	CbGbCtD
Solifenacin—CYP3A4—Crizotinib—lung cancer	0.0292	0.0796	CbGbCtD
Solifenacin—CYP3A4—Erlotinib—lung cancer	0.0281	0.0768	CbGbCtD
Solifenacin—CYP3A4—Paclitaxel—lung cancer	0.0258	0.0703	CbGbCtD
Solifenacin—CYP3A4—Irinotecan—lung cancer	0.0254	0.0694	CbGbCtD
Solifenacin—CYP3A4—Vinblastine—lung cancer	0.0226	0.0617	CbGbCtD
Solifenacin—CYP3A4—Etoposide—lung cancer	0.0204	0.0556	CbGbCtD
Solifenacin—CYP3A4—Docetaxel—lung cancer	0.0186	0.0508	CbGbCtD
Solifenacin—CYP3A4—Doxorubicin—lung cancer	0.0139	0.0379	CbGbCtD
Solifenacin—Dermatitis—Topotecan—lung cancer	0.000506	0.000982	CcSEcCtD
Solifenacin—Vomiting—Erlotinib—lung cancer	0.000505	0.000981	CcSEcCtD
Solifenacin—Nervous system disorder—Cisplatin—lung cancer	0.000504	0.000979	CcSEcCtD
Solifenacin—Cough—Etoposide—lung cancer	0.000504	0.000978	CcSEcCtD
Solifenacin—Somnolence—Irinotecan—lung cancer	0.000504	0.000978	CcSEcCtD
Solifenacin—Headache—Topotecan—lung cancer	0.000503	0.000977	CcSEcCtD
Solifenacin—Tachycardia—Cisplatin—lung cancer	0.000502	0.000975	CcSEcCtD
Solifenacin—Rash—Erlotinib—lung cancer	0.000501	0.000972	CcSEcCtD
Solifenacin—Dermatitis—Erlotinib—lung cancer	0.0005	0.000972	CcSEcCtD
Solifenacin—Palpitations—Paclitaxel—lung cancer	0.0005	0.000971	CcSEcCtD
Solifenacin—Angiopathy—Docetaxel—lung cancer	0.0005	0.000971	CcSEcCtD
Solifenacin—Skin disorder—Cisplatin—lung cancer	0.0005	0.00097	CcSEcCtD
Solifenacin—Dyspepsia—Irinotecan—lung cancer	0.000499	0.000968	CcSEcCtD
Solifenacin—Hypertension—Etoposide—lung cancer	0.000498	0.000968	CcSEcCtD
Solifenacin—Immune system disorder—Docetaxel—lung cancer	0.000498	0.000967	CcSEcCtD
Solifenacin—Headache—Erlotinib—lung cancer	0.000498	0.000966	CcSEcCtD
Solifenacin—Mediastinal disorder—Docetaxel—lung cancer	0.000497	0.000964	CcSEcCtD
Solifenacin—Cough—Paclitaxel—lung cancer	0.000494	0.000959	CcSEcCtD
Solifenacin—Asthenia—Vinorelbine—lung cancer	0.000493	0.000957	CcSEcCtD
Solifenacin—Decreased appetite—Irinotecan—lung cancer	0.000492	0.000956	CcSEcCtD
Solifenacin—Nausea—Vinblastine—lung cancer	0.000491	0.000953	CcSEcCtD
Solifenacin—Somnolence—Gemcitabine—lung cancer	0.000491	0.000952	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Irinotecan—lung cancer	0.000489	0.00095	CcSEcCtD
Solifenacin—Hypertension—Paclitaxel—lung cancer	0.000489	0.000949	CcSEcCtD
Solifenacin—Fatigue—Irinotecan—lung cancer	0.000488	0.000948	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000488	0.000948	CcSEcCtD
Solifenacin—Pruritus—Vinorelbine—lung cancer	0.000486	0.000943	CcSEcCtD
Solifenacin—Constipation—Irinotecan—lung cancer	0.000484	0.000941	CcSEcCtD
Solifenacin—Mental disorder—Docetaxel—lung cancer	0.000483	0.000938	CcSEcCtD
Solifenacin—Malnutrition—Docetaxel—lung cancer	0.00048	0.000932	CcSEcCtD
Solifenacin—Decreased appetite—Gemcitabine—lung cancer	0.00048	0.000931	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000479	0.000929	CcSEcCtD
Solifenacin—Nausea—Topotecan—lung cancer	0.000477	0.000926	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000476	0.000925	CcSEcCtD
Solifenacin—Fatigue—Gemcitabine—lung cancer	0.000476	0.000924	CcSEcCtD
Solifenacin—Confusional state—Etoposide—lung cancer	0.000475	0.000922	CcSEcCtD
Solifenacin—Constipation—Gemcitabine—lung cancer	0.000472	0.000916	CcSEcCtD
Solifenacin—Nausea—Erlotinib—lung cancer	0.000472	0.000916	CcSEcCtD
Solifenacin—Dry mouth—Paclitaxel—lung cancer	0.000471	0.000915	CcSEcCtD
Solifenacin—Anaphylactic shock—Etoposide—lung cancer	0.000471	0.000915	CcSEcCtD
Solifenacin—Dysgeusia—Docetaxel—lung cancer	0.00047	0.000912	CcSEcCtD
Solifenacin—Infection—Etoposide—lung cancer	0.000468	0.000909	CcSEcCtD
Solifenacin—Feeling abnormal—Irinotecan—lung cancer	0.000467	0.000906	CcSEcCtD
Solifenacin—Confusional state—Paclitaxel—lung cancer	0.000466	0.000904	CcSEcCtD
Solifenacin—Dysuria—Methotrexate—lung cancer	0.000464	0.000901	CcSEcCtD
Solifenacin—Gastrointestinal pain—Irinotecan—lung cancer	0.000463	0.000899	CcSEcCtD
Solifenacin—Anaphylactic shock—Paclitaxel—lung cancer	0.000462	0.000897	CcSEcCtD
Solifenacin—Tachycardia—Etoposide—lung cancer	0.00046	0.000893	CcSEcCtD
Solifenacin—Liver function test abnormal—Doxorubicin—lung cancer	0.000459	0.000891	CcSEcCtD
Solifenacin—Infection—Paclitaxel—lung cancer	0.000459	0.000891	CcSEcCtD
Solifenacin—Skin disorder—Etoposide—lung cancer	0.000458	0.000889	CcSEcCtD
Solifenacin—Dry skin—Doxorubicin—lung cancer	0.000456	0.000885	CcSEcCtD
Solifenacin—Feeling abnormal—Gemcitabine—lung cancer	0.000455	0.000883	CcSEcCtD
Solifenacin—Dizziness—Vinorelbine—lung cancer	0.000454	0.000882	CcSEcCtD
Solifenacin—Abdominal pain upper—Doxorubicin—lung cancer	0.000454	0.000882	CcSEcCtD
Solifenacin—Nervous system disorder—Paclitaxel—lung cancer	0.000453	0.00088	CcSEcCtD
Solifenacin—Tachycardia—Paclitaxel—lung cancer	0.000451	0.000875	CcSEcCtD
Solifenacin—Skin disorder—Paclitaxel—lung cancer	0.000449	0.000871	CcSEcCtD
Solifenacin—Abdominal pain—Irinotecan—lung cancer	0.000448	0.000869	CcSEcCtD
Solifenacin—Decreased appetite—Cisplatin—lung cancer	0.000447	0.000868	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Cisplatin—lung cancer	0.000444	0.000862	CcSEcCtD
Solifenacin—Infestation NOS—Methotrexate—lung cancer	0.000443	0.000859	CcSEcCtD
Solifenacin—Infestation—Methotrexate—lung cancer	0.000443	0.000859	CcSEcCtD
Solifenacin—Depression—Methotrexate—lung cancer	0.000441	0.000857	CcSEcCtD
Solifenacin—Muscular weakness—Doxorubicin—lung cancer	0.000439	0.000851	CcSEcCtD
Solifenacin—Vomiting—Vinorelbine—lung cancer	0.000437	0.000848	CcSEcCtD
Solifenacin—Renal failure—Methotrexate—lung cancer	0.000435	0.000845	CcSEcCtD
Solifenacin—Rash—Vinorelbine—lung cancer	0.000433	0.000841	CcSEcCtD
Solifenacin—Dermatitis—Vinorelbine—lung cancer	0.000433	0.00084	CcSEcCtD
Solifenacin—Headache—Vinorelbine—lung cancer	0.00043	0.000835	CcSEcCtD
Solifenacin—Influenza—Doxorubicin—lung cancer	0.00043	0.000834	CcSEcCtD
Solifenacin—Palpitations—Docetaxel—lung cancer	0.000424	0.000823	CcSEcCtD
Solifenacin—Feeling abnormal—Cisplatin—lung cancer	0.000424	0.000823	CcSEcCtD
Solifenacin—Somnolence—Etoposide—lung cancer	0.000419	0.000813	CcSEcCtD
Solifenacin—Cough—Docetaxel—lung cancer	0.000419	0.000813	CcSEcCtD
Solifenacin—Hepatobiliary disease—Methotrexate—lung cancer	0.000419	0.000813	CcSEcCtD
Solifenacin—Hypersensitivity—Irinotecan—lung cancer	0.000417	0.00081	CcSEcCtD
Solifenacin—Hypertension—Docetaxel—lung cancer	0.000414	0.000804	CcSEcCtD
Solifenacin—Somnolence—Paclitaxel—lung cancer	0.000411	0.000797	CcSEcCtD
Solifenacin—Decreased appetite—Etoposide—lung cancer	0.00041	0.000795	CcSEcCtD
Solifenacin—Nausea—Vinorelbine—lung cancer	0.000408	0.000792	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Etoposide—lung cancer	0.000407	0.00079	CcSEcCtD
Solifenacin—Dyspepsia—Paclitaxel—lung cancer	0.000407	0.00079	CcSEcCtD
Solifenacin—Asthenia—Irinotecan—lung cancer	0.000406	0.000789	CcSEcCtD
Solifenacin—Fatigue—Etoposide—lung cancer	0.000406	0.000789	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000406	0.000788	CcSEcCtD
Solifenacin—Constipation—Etoposide—lung cancer	0.000403	0.000782	CcSEcCtD
Solifenacin—Dysuria—Doxorubicin—lung cancer	0.000402	0.00078	CcSEcCtD
Solifenacin—Decreased appetite—Paclitaxel—lung cancer	0.000402	0.00078	CcSEcCtD
Solifenacin—Dry mouth—Docetaxel—lung cancer	0.000399	0.000776	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000399	0.000774	CcSEcCtD
Solifenacin—Fatigue—Paclitaxel—lung cancer	0.000398	0.000773	CcSEcCtD
Solifenacin—Asthenia—Gemcitabine—lung cancer	0.000396	0.000769	CcSEcCtD
Solifenacin—Constipation—Paclitaxel—lung cancer	0.000395	0.000767	CcSEcCtD
Solifenacin—Confusional state—Docetaxel—lung cancer	0.000395	0.000767	CcSEcCtD
Solifenacin—Pharyngitis—Methotrexate—lung cancer	0.000394	0.000766	CcSEcCtD
Solifenacin—Urinary tract disorder—Methotrexate—lung cancer	0.000392	0.000762	CcSEcCtD
Solifenacin—Anaphylactic shock—Docetaxel—lung cancer	0.000392	0.00076	CcSEcCtD
Solifenacin—Pruritus—Gemcitabine—lung cancer	0.00039	0.000758	CcSEcCtD
Solifenacin—Urethral disorder—Methotrexate—lung cancer	0.000389	0.000756	CcSEcCtD
Solifenacin—Infection—Docetaxel—lung cancer	0.000389	0.000755	CcSEcCtD
Solifenacin—Feeling abnormal—Etoposide—lung cancer	0.000388	0.000754	CcSEcCtD
Solifenacin—Gastrointestinal pain—Etoposide—lung cancer	0.000385	0.000748	CcSEcCtD
Solifenacin—Nervous system disorder—Docetaxel—lung cancer	0.000384	0.000746	CcSEcCtD
Solifenacin—Infestation NOS—Doxorubicin—lung cancer	0.000383	0.000744	CcSEcCtD
Solifenacin—Infestation—Doxorubicin—lung cancer	0.000383	0.000744	CcSEcCtD
Solifenacin—Tachycardia—Docetaxel—lung cancer	0.000382	0.000742	CcSEcCtD
Solifenacin—Feeling abnormal—Paclitaxel—lung cancer	0.000381	0.000739	CcSEcCtD
Solifenacin—Skin disorder—Docetaxel—lung cancer	0.00038	0.000738	CcSEcCtD
Solifenacin—Hypersensitivity—Cisplatin—lung cancer	0.000379	0.000736	CcSEcCtD
Solifenacin—Gastrointestinal pain—Paclitaxel—lung cancer	0.000378	0.000733	CcSEcCtD
Solifenacin—Renal failure—Doxorubicin—lung cancer	0.000377	0.000731	CcSEcCtD
Solifenacin—Erythema multiforme—Methotrexate—lung cancer	0.000376	0.000729	CcSEcCtD
Solifenacin—Dizziness—Irinotecan—lung cancer	0.000375	0.000727	CcSEcCtD
Solifenacin—Urticaria—Etoposide—lung cancer	0.000374	0.000727	CcSEcCtD
Solifenacin—Abdominal pain—Etoposide—lung cancer	0.000372	0.000723	CcSEcCtD
Solifenacin—Urinary tract infection—Doxorubicin—lung cancer	0.000372	0.000723	CcSEcCtD
Solifenacin—Eye disorder—Methotrexate—lung cancer	0.000371	0.000721	CcSEcCtD
Solifenacin—Asthenia—Cisplatin—lung cancer	0.000369	0.000716	CcSEcCtD
Solifenacin—Cardiac disorder—Methotrexate—lung cancer	0.000369	0.000716	CcSEcCtD
Solifenacin—Urticaria—Paclitaxel—lung cancer	0.000367	0.000713	CcSEcCtD
Solifenacin—Abdominal pain—Paclitaxel—lung cancer	0.000365	0.000709	CcSEcCtD
Solifenacin—Hepatobiliary disease—Doxorubicin—lung cancer	0.000362	0.000704	CcSEcCtD
Solifenacin—Angiopathy—Methotrexate—lung cancer	0.00036	0.0007	CcSEcCtD
Solifenacin—Vomiting—Irinotecan—lung cancer	0.00036	0.000699	CcSEcCtD
Solifenacin—Immune system disorder—Methotrexate—lung cancer	0.000359	0.000697	CcSEcCtD
Solifenacin—Mediastinal disorder—Methotrexate—lung cancer	0.000358	0.000695	CcSEcCtD
Solifenacin—Rash—Irinotecan—lung cancer	0.000357	0.000693	CcSEcCtD
Solifenacin—Dermatitis—Irinotecan—lung cancer	0.000357	0.000693	CcSEcCtD
Solifenacin—Headache—Irinotecan—lung cancer	0.000355	0.000689	CcSEcCtD
Solifenacin—Vomiting—Gemcitabine—lung cancer	0.000351	0.000681	CcSEcCtD
Solifenacin—Somnolence—Docetaxel—lung cancer	0.000348	0.000676	CcSEcCtD
Solifenacin—Mental disorder—Methotrexate—lung cancer	0.000348	0.000676	CcSEcCtD
Solifenacin—Rash—Gemcitabine—lung cancer	0.000348	0.000676	CcSEcCtD
Solifenacin—Dermatitis—Gemcitabine—lung cancer	0.000348	0.000675	CcSEcCtD
Solifenacin—Hypersensitivity—Etoposide—lung cancer	0.000347	0.000674	CcSEcCtD
Solifenacin—Malnutrition—Methotrexate—lung cancer	0.000346	0.000671	CcSEcCtD
Solifenacin—Headache—Gemcitabine—lung cancer	0.000346	0.000671	CcSEcCtD
Solifenacin—Dyspepsia—Docetaxel—lung cancer	0.000345	0.000669	CcSEcCtD
Solifenacin—Pharyngitis—Doxorubicin—lung cancer	0.000341	0.000663	CcSEcCtD
Solifenacin—Decreased appetite—Docetaxel—lung cancer	0.00034	0.000661	CcSEcCtD
Solifenacin—Hypersensitivity—Paclitaxel—lung cancer	0.00034	0.000661	CcSEcCtD
Solifenacin—Urinary tract disorder—Doxorubicin—lung cancer	0.00034	0.00066	CcSEcCtD
Solifenacin—Oedema peripheral—Doxorubicin—lung cancer	0.000339	0.000658	CcSEcCtD
Solifenacin—Dysgeusia—Methotrexate—lung cancer	0.000339	0.000658	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Docetaxel—lung cancer	0.000338	0.000656	CcSEcCtD
Solifenacin—Asthenia—Etoposide—lung cancer	0.000338	0.000656	CcSEcCtD
Solifenacin—Connective tissue disorder—Doxorubicin—lung cancer	0.000338	0.000656	CcSEcCtD
Solifenacin—Fatigue—Docetaxel—lung cancer	0.000338	0.000655	CcSEcCtD
Solifenacin—Urethral disorder—Doxorubicin—lung cancer	0.000337	0.000655	CcSEcCtD
Solifenacin—Nausea—Irinotecan—lung cancer	0.000336	0.000653	CcSEcCtD
Solifenacin—Constipation—Docetaxel—lung cancer	0.000335	0.00065	CcSEcCtD
Solifenacin—Pruritus—Etoposide—lung cancer	0.000333	0.000647	CcSEcCtD
Solifenacin—Asthenia—Paclitaxel—lung cancer	0.000331	0.000644	CcSEcCtD
Solifenacin—Nausea—Gemcitabine—lung cancer	0.000328	0.000636	CcSEcCtD
Solifenacin—Vomiting—Cisplatin—lung cancer	0.000327	0.000635	CcSEcCtD
Solifenacin—Pruritus—Paclitaxel—lung cancer	0.000327	0.000635	CcSEcCtD
Solifenacin—Vision blurred—Methotrexate—lung cancer	0.000326	0.000633	CcSEcCtD
Solifenacin—Erythema multiforme—Doxorubicin—lung cancer	0.000325	0.000631	CcSEcCtD
Solifenacin—Rash—Cisplatin—lung cancer	0.000324	0.00063	CcSEcCtD
Solifenacin—Dermatitis—Cisplatin—lung cancer	0.000324	0.000629	CcSEcCtD
Solifenacin—Feeling abnormal—Docetaxel—lung cancer	0.000323	0.000627	CcSEcCtD
Solifenacin—Eye disorder—Doxorubicin—lung cancer	0.000321	0.000624	CcSEcCtD
Solifenacin—Gastrointestinal pain—Docetaxel—lung cancer	0.00032	0.000622	CcSEcCtD
Solifenacin—Cardiac disorder—Doxorubicin—lung cancer	0.000319	0.00062	CcSEcCtD
Solifenacin—Angiopathy—Doxorubicin—lung cancer	0.000312	0.000606	CcSEcCtD
Solifenacin—Dizziness—Etoposide—lung cancer	0.000312	0.000605	CcSEcCtD
Solifenacin—Immune system disorder—Doxorubicin—lung cancer	0.000311	0.000603	CcSEcCtD
Solifenacin—Mediastinal disorder—Doxorubicin—lung cancer	0.00031	0.000602	CcSEcCtD
Solifenacin—Abdominal pain—Docetaxel—lung cancer	0.00031	0.000601	CcSEcCtD
Solifenacin—Dizziness—Paclitaxel—lung cancer	0.000305	0.000593	CcSEcCtD
Solifenacin—Nausea—Cisplatin—lung cancer	0.000305	0.000593	CcSEcCtD
Solifenacin—Cough—Methotrexate—lung cancer	0.000302	0.000586	CcSEcCtD
Solifenacin—Mental disorder—Doxorubicin—lung cancer	0.000301	0.000585	CcSEcCtD
Solifenacin—Vomiting—Etoposide—lung cancer	0.0003	0.000582	CcSEcCtD
Solifenacin—Malnutrition—Doxorubicin—lung cancer	0.000299	0.000581	CcSEcCtD
Solifenacin—Rash—Etoposide—lung cancer	0.000297	0.000577	CcSEcCtD
Solifenacin—Dermatitis—Etoposide—lung cancer	0.000297	0.000576	CcSEcCtD
Solifenacin—Headache—Etoposide—lung cancer	0.000295	0.000573	CcSEcCtD
Solifenacin—Vomiting—Paclitaxel—lung cancer	0.000294	0.00057	CcSEcCtD
Solifenacin—Dysgeusia—Doxorubicin—lung cancer	0.000293	0.000569	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000292	0.000568	CcSEcCtD
Solifenacin—Rash—Paclitaxel—lung cancer	0.000291	0.000566	CcSEcCtD
Solifenacin—Dermatitis—Paclitaxel—lung cancer	0.000291	0.000565	CcSEcCtD
Solifenacin—Headache—Paclitaxel—lung cancer	0.000289	0.000562	CcSEcCtD
Solifenacin—Hypersensitivity—Docetaxel—lung cancer	0.000288	0.00056	CcSEcCtD
Solifenacin—Confusional state—Methotrexate—lung cancer	0.000285	0.000553	CcSEcCtD
Solifenacin—Anaphylactic shock—Methotrexate—lung cancer	0.000282	0.000548	CcSEcCtD
Solifenacin—Vision blurred—Doxorubicin—lung cancer	0.000282	0.000548	CcSEcCtD
Solifenacin—Asthenia—Docetaxel—lung cancer	0.000281	0.000545	CcSEcCtD
Solifenacin—Infection—Methotrexate—lung cancer	0.00028	0.000544	CcSEcCtD
Solifenacin—Nausea—Etoposide—lung cancer	0.00028	0.000543	CcSEcCtD
Solifenacin—Pruritus—Docetaxel—lung cancer	0.000277	0.000538	CcSEcCtD
Solifenacin—Nervous system disorder—Methotrexate—lung cancer	0.000277	0.000537	CcSEcCtD
Solifenacin—Nausea—Paclitaxel—lung cancer	0.000274	0.000533	CcSEcCtD
Solifenacin—Skin disorder—Methotrexate—lung cancer	0.000274	0.000532	CcSEcCtD
Solifenacin—Palpitations—Doxorubicin—lung cancer	0.000265	0.000514	CcSEcCtD
Solifenacin—Cough—Doxorubicin—lung cancer	0.000261	0.000507	CcSEcCtD
Solifenacin—Dizziness—Docetaxel—lung cancer	0.000259	0.000503	CcSEcCtD
Solifenacin—Hypertension—Doxorubicin—lung cancer	0.000259	0.000502	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000253	0.000492	CcSEcCtD
Solifenacin—Somnolence—Methotrexate—lung cancer	0.000251	0.000487	CcSEcCtD
Solifenacin—Dry mouth—Doxorubicin—lung cancer	0.000249	0.000484	CcSEcCtD
Solifenacin—Vomiting—Docetaxel—lung cancer	0.000249	0.000483	CcSEcCtD
Solifenacin—Dyspepsia—Methotrexate—lung cancer	0.000248	0.000482	CcSEcCtD
Solifenacin—Rash—Docetaxel—lung cancer	0.000247	0.000479	CcSEcCtD
Solifenacin—Dermatitis—Docetaxel—lung cancer	0.000247	0.000479	CcSEcCtD
Solifenacin—Confusional state—Doxorubicin—lung cancer	0.000246	0.000478	CcSEcCtD
Solifenacin—Decreased appetite—Methotrexate—lung cancer	0.000245	0.000476	CcSEcCtD
Solifenacin—Headache—Docetaxel—lung cancer	0.000245	0.000476	CcSEcCtD
Solifenacin—Anaphylactic shock—Doxorubicin—lung cancer	0.000244	0.000474	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Methotrexate—lung cancer	0.000244	0.000473	CcSEcCtD
Solifenacin—Fatigue—Methotrexate—lung cancer	0.000243	0.000472	CcSEcCtD
Solifenacin—Infection—Doxorubicin—lung cancer	0.000243	0.000471	CcSEcCtD
Solifenacin—Nervous system disorder—Doxorubicin—lung cancer	0.00024	0.000465	CcSEcCtD
Solifenacin—Tachycardia—Doxorubicin—lung cancer	0.000239	0.000463	CcSEcCtD
Solifenacin—Skin disorder—Doxorubicin—lung cancer	0.000237	0.000461	CcSEcCtD
Solifenacin—Nausea—Docetaxel—lung cancer	0.000233	0.000452	CcSEcCtD
Solifenacin—Feeling abnormal—Methotrexate—lung cancer	0.000233	0.000452	CcSEcCtD
Solifenacin—Gastrointestinal pain—Methotrexate—lung cancer	0.000231	0.000448	CcSEcCtD
Solifenacin—Urticaria—Methotrexate—lung cancer	0.000224	0.000435	CcSEcCtD
Solifenacin—Abdominal pain—Methotrexate—lung cancer	0.000223	0.000433	CcSEcCtD
Solifenacin—Somnolence—Doxorubicin—lung cancer	0.000217	0.000422	CcSEcCtD
Solifenacin—Dyspepsia—Doxorubicin—lung cancer	0.000215	0.000418	CcSEcCtD
Solifenacin—Decreased appetite—Doxorubicin—lung cancer	0.000212	0.000412	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000211	0.00041	CcSEcCtD
Solifenacin—Fatigue—Doxorubicin—lung cancer	0.000211	0.000409	CcSEcCtD
Solifenacin—Constipation—Doxorubicin—lung cancer	0.000209	0.000406	CcSEcCtD
Solifenacin—Hypersensitivity—Methotrexate—lung cancer	0.000208	0.000404	CcSEcCtD
Solifenacin—Asthenia—Methotrexate—lung cancer	0.000202	0.000393	CcSEcCtD
Solifenacin—Feeling abnormal—Doxorubicin—lung cancer	0.000201	0.000391	CcSEcCtD
Solifenacin—Gastrointestinal pain—Doxorubicin—lung cancer	0.0002	0.000388	CcSEcCtD
Solifenacin—Pruritus—Methotrexate—lung cancer	0.0002	0.000388	CcSEcCtD
Solifenacin—Urticaria—Doxorubicin—lung cancer	0.000194	0.000377	CcSEcCtD
Solifenacin—Abdominal pain—Doxorubicin—lung cancer	0.000193	0.000375	CcSEcCtD
Solifenacin—Dizziness—Methotrexate—lung cancer	0.000187	0.000362	CcSEcCtD
Solifenacin—Hypersensitivity—Doxorubicin—lung cancer	0.00018	0.00035	CcSEcCtD
Solifenacin—Vomiting—Methotrexate—lung cancer	0.000179	0.000348	CcSEcCtD
Solifenacin—Rash—Methotrexate—lung cancer	0.000178	0.000346	CcSEcCtD
Solifenacin—Dermatitis—Methotrexate—lung cancer	0.000178	0.000345	CcSEcCtD
Solifenacin—Headache—Methotrexate—lung cancer	0.000177	0.000343	CcSEcCtD
Solifenacin—Asthenia—Doxorubicin—lung cancer	0.000175	0.00034	CcSEcCtD
Solifenacin—Pruritus—Doxorubicin—lung cancer	0.000173	0.000336	CcSEcCtD
Solifenacin—Nausea—Methotrexate—lung cancer	0.000168	0.000325	CcSEcCtD
Solifenacin—Dizziness—Doxorubicin—lung cancer	0.000162	0.000314	CcSEcCtD
Solifenacin—Vomiting—Doxorubicin—lung cancer	0.000155	0.000302	CcSEcCtD
Solifenacin—Rash—Doxorubicin—lung cancer	0.000154	0.000299	CcSEcCtD
Solifenacin—Dermatitis—Doxorubicin—lung cancer	0.000154	0.000299	CcSEcCtD
Solifenacin—Headache—Doxorubicin—lung cancer	0.000153	0.000297	CcSEcCtD
Solifenacin—Nausea—Doxorubicin—lung cancer	0.000145	0.000282	CcSEcCtD
Solifenacin—CHRM3—Metabolism—POMC—lung cancer	2.03e-05	0.000171	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HIF1A—lung cancer	2.02e-05	0.00017	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—PIK3CA—lung cancer	2.01e-05	0.000169	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HIF1A—lung cancer	2e-05	0.000169	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MDM2—lung cancer	2e-05	0.000168	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—RAF1—lung cancer	1.99e-05	0.000168	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CREBBP—lung cancer	1.97e-05	0.000166	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—ERBB2—lung cancer	1.97e-05	0.000166	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ALDOA—lung cancer	1.96e-05	0.000165	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—APOA1—lung cancer	1.96e-05	0.000165	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CXCL8—lung cancer	1.95e-05	0.000164	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—APOA1—lung cancer	1.95e-05	0.000164	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MTOR—lung cancer	1.94e-05	0.000164	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PIK3CB—lung cancer	1.94e-05	0.000164	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—KDR—lung cancer	1.94e-05	0.000163	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—HRAS—lung cancer	1.94e-05	0.000163	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—KDR—lung cancer	1.93e-05	0.000163	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—APOA1—lung cancer	1.93e-05	0.000163	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—KDR—lung cancer	1.91e-05	0.000161	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—NCOA3—lung cancer	1.9e-05	0.00016	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—AKT1—lung cancer	1.88e-05	0.000159	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PIK3CD—lung cancer	1.87e-05	0.000158	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CXCL8—lung cancer	1.87e-05	0.000157	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CASP3—lung cancer	1.87e-05	0.000157	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL2—lung cancer	1.86e-05	0.000157	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—HRAS—lung cancer	1.86e-05	0.000156	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—IL6—lung cancer	1.85e-05	0.000156	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ADCY1—lung cancer	1.85e-05	0.000156	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ABCG2—lung cancer	1.85e-05	0.000156	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—ALB—lung cancer	1.85e-05	0.000156	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CCND1—lung cancer	1.82e-05	0.000153	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—HPGDS—lung cancer	1.81e-05	0.000153	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ENO2—lung cancer	1.81e-05	0.000153	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—JUN—lung cancer	1.81e-05	0.000153	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—AKT1—lung cancer	1.8e-05	0.000152	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.8e-05	0.000152	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CASP3—lung cancer	1.79e-05	0.000151	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PIK3CG—lung cancer	1.79e-05	0.000151	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—APC—lung cancer	1.79e-05	0.000151	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—KIT—lung cancer	1.79e-05	0.000151	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—NRAS—lung cancer	1.79e-05	0.000151	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL2—lung cancer	1.79e-05	0.00015	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—KIT—lung cancer	1.78e-05	0.00015	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PIK3CG—lung cancer	1.78e-05	0.00015	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—APC—lung cancer	1.78e-05	0.00015	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—NRAS—lung cancer	1.78e-05	0.00015	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—IL6—lung cancer	1.78e-05	0.00015	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—EGF—lung cancer	1.77e-05	0.000149	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MMP9—lung cancer	1.76e-05	0.000149	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—APC—lung cancer	1.76e-05	0.000149	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—KIT—lung cancer	1.76e-05	0.000149	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PIK3CG—lung cancer	1.76e-05	0.000149	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—NRAS—lung cancer	1.76e-05	0.000149	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GSTT1—lung cancer	1.76e-05	0.000148	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—EGF—lung cancer	1.76e-05	0.000148	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CDKN1A—lung cancer	1.76e-05	0.000148	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PTEN—lung cancer	1.75e-05	0.000148	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—EGF—lung cancer	1.74e-05	0.000147	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CCND1—lung cancer	1.74e-05	0.000147	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GCLC—lung cancer	1.74e-05	0.000147	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYP2A6—lung cancer	1.74e-05	0.000147	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—JUN—lung cancer	1.74e-05	0.000146	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—AKT1—lung cancer	1.71e-05	0.000144	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—MAPK3—lung cancer	1.71e-05	0.000144	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—MAPK3—lung cancer	1.71e-05	0.000144	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—POMC—lung cancer	1.7e-05	0.000143	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—POMC—lung cancer	1.69e-05	0.000143	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MMP9—lung cancer	1.69e-05	0.000142	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—MAPK3—lung cancer	1.69e-05	0.000142	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CDKN1A—lung cancer	1.68e-05	0.000142	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PTEN—lung cancer	1.68e-05	0.000142	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—BRAF—lung cancer	1.68e-05	0.000141	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—POMC—lung cancer	1.68e-05	0.000141	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—BRAF—lung cancer	1.67e-05	0.000141	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—EP300—lung cancer	1.67e-05	0.000141	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL6R—lung cancer	1.66e-05	0.00014	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—BRAF—lung cancer	1.66e-05	0.00014	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CREBBP—lung cancer	1.66e-05	0.00014	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL6R—lung cancer	1.65e-05	0.000139	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CREBBP—lung cancer	1.65e-05	0.000139	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ENO1—lung cancer	1.65e-05	0.000139	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—AKT1—lung cancer	1.64e-05	0.000138	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL6R—lung cancer	1.64e-05	0.000138	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CREBBP—lung cancer	1.63e-05	0.000138	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PIK3CB—lung cancer	1.63e-05	0.000137	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—EGFR—lung cancer	1.63e-05	0.000137	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—SRC—lung cancer	1.63e-05	0.000137	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—EGFR—lung cancer	1.62e-05	0.000137	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PTGS2—lung cancer	1.62e-05	0.000136	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—EGFR—lung cancer	1.61e-05	0.000135	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—EP300—lung cancer	1.6e-05	0.000135	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—VEGFA—lung cancer	1.58e-05	0.000133	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MAP2K1—lung cancer	1.58e-05	0.000133	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MAP2K1—lung cancer	1.58e-05	0.000133	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PIK3CD—lung cancer	1.57e-05	0.000132	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—STAT3—lung cancer	1.57e-05	0.000132	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PIK3CD—lung cancer	1.57e-05	0.000132	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NRAS—lung cancer	1.56e-05	0.000132	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MAP2K1—lung cancer	1.56e-05	0.000131	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—SRC—lung cancer	1.56e-05	0.000131	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—PIK3CA—lung cancer	1.56e-05	0.000131	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—PIK3CA—lung cancer	1.55e-05	0.000131	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PIK3CD—lung cancer	1.55e-05	0.000131	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—KRAS—lung cancer	1.54e-05	0.00013	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—PIK3CA—lung cancer	1.54e-05	0.000129	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—KRAS—lung cancer	1.53e-05	0.000129	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—KRAS—lung cancer	1.52e-05	0.000128	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—VEGFA—lung cancer	1.52e-05	0.000128	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—STAT3—lung cancer	1.5e-05	0.000127	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MAPK3—lung cancer	1.5e-05	0.000126	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NRAS—lung cancer	1.5e-05	0.000126	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYP2E1—lung cancer	1.48e-05	0.000125	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—NQO1—lung cancer	1.46e-05	0.000123	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MYC—lung cancer	1.46e-05	0.000123	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MAPK3—lung cancer	1.44e-05	0.000121	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—EGFR—lung cancer	1.43e-05	0.00012	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—PIK3CA—lung cancer	1.41e-05	0.000119	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PTEN—lung cancer	1.41e-05	0.000119	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—PIK3CA—lung cancer	1.41e-05	0.000119	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MDM2—lung cancer	1.41e-05	0.000119	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MDM2—lung cancer	1.4e-05	0.000118	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—RAF1—lung cancer	1.4e-05	0.000118	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—RAF1—lung cancer	1.4e-05	0.000118	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MYC—lung cancer	1.4e-05	0.000118	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—PIK3CA—lung cancer	1.39e-05	0.000117	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MDM2—lung cancer	1.39e-05	0.000117	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—ERBB2—lung cancer	1.39e-05	0.000117	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—RAF1—lung cancer	1.38e-05	0.000117	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—ERBB2—lung cancer	1.38e-05	0.000116	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—ERBB2—lung cancer	1.37e-05	0.000115	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MTOR—lung cancer	1.37e-05	0.000115	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PIK3CB—lung cancer	1.37e-05	0.000115	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—EGFR—lung cancer	1.37e-05	0.000115	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PIK3CB—lung cancer	1.36e-05	0.000115	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MTOR—lung cancer	1.36e-05	0.000115	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PIK3CB—lung cancer	1.35e-05	0.000114	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MTOR—lung cancer	1.35e-05	0.000114	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—KRAS—lung cancer	1.35e-05	0.000113	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—EP300—lung cancer	1.34e-05	0.000113	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—STK11—lung cancer	1.32e-05	0.000111	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CXCL8—lung cancer	1.32e-05	0.000111	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CXCL8—lung cancer	1.31e-05	0.00011	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—HRAS—lung cancer	1.31e-05	0.00011	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—HRAS—lung cancer	1.3e-05	0.00011	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CXCL8—lung cancer	1.3e-05	0.000109	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—HRAS—lung cancer	1.29e-05	0.000109	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—KRAS—lung cancer	1.29e-05	0.000109	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—AKT1—lung cancer	1.27e-05	0.000107	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—AKT1—lung cancer	1.27e-05	0.000107	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CASP3—lung cancer	1.26e-05	0.000106	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL2—lung cancer	1.26e-05	0.000106	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CASP3—lung cancer	1.25e-05	0.000106	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—AKT1—lung cancer	1.25e-05	0.000106	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL2—lung cancer	1.25e-05	0.000106	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—IL6—lung cancer	1.25e-05	0.000105	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—IL6—lung cancer	1.25e-05	0.000105	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CASP3—lung cancer	1.24e-05	0.000105	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL2—lung cancer	1.24e-05	0.000105	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PIK3CA—lung cancer	1.24e-05	0.000104	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—IL6—lung cancer	1.23e-05	0.000104	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CCND1—lung cancer	1.23e-05	0.000103	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—JUN—lung cancer	1.22e-05	0.000103	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCND1—lung cancer	1.22e-05	0.000103	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GSTP1—lung cancer	1.22e-05	0.000103	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—JUN—lung cancer	1.22e-05	0.000103	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCND1—lung cancer	1.21e-05	0.000102	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—JUN—lung cancer	1.21e-05	0.000102	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TP53—lung cancer	1.2e-05	0.000101	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MMP9—lung cancer	1.19e-05	0.0001	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CAT—lung cancer	1.19e-05	0.0001	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MMP9—lung cancer	1.19e-05	9.99e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CDKN1A—lung cancer	1.19e-05	9.99e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PIK3CA—lung cancer	1.18e-05	9.98e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PTEN—lung cancer	1.18e-05	9.97e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CDKN1A—lung cancer	1.18e-05	9.96e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PTEN—lung cancer	1.18e-05	9.93e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MMP9—lung cancer	1.17e-05	9.9e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CDKN1A—lung cancer	1.17e-05	9.86e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PTEN—lung cancer	1.17e-05	9.84e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ABCB1—lung cancer	1.15e-05	9.73e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—AKT1—lung cancer	1.15e-05	9.72e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—AKT1—lung cancer	1.15e-05	9.69e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TP53—lung cancer	1.15e-05	9.66e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—HRAS—lung cancer	1.14e-05	9.65e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—AKT1—lung cancer	1.14e-05	9.6e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—TYMS—lung cancer	1.13e-05	9.56e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—EP300—lung cancer	1.13e-05	9.5e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—EP300—lung cancer	1.12e-05	9.47e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GSTM1—lung cancer	1.12e-05	9.45e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—EP300—lung cancer	1.11e-05	9.38e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—SRC—lung cancer	1.1e-05	9.24e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—HRAS—lung cancer	1.1e-05	9.24e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL6—lung cancer	1.1e-05	9.23e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—SRC—lung cancer	1.09e-05	9.21e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—SRC—lung cancer	1.08e-05	9.12e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—VEGFA—lung cancer	1.07e-05	9e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—VEGFA—lung cancer	1.06e-05	8.97e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYP1A1—lung cancer	1.06e-05	8.96e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—STAT3—lung cancer	1.06e-05	8.91e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NRAS—lung cancer	1.06e-05	8.89e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—VEGFA—lung cancer	1.05e-05	8.89e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—STAT3—lung cancer	1.05e-05	8.88e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ERCC2—lung cancer	1.05e-05	8.88e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NRAS—lung cancer	1.05e-05	8.86e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL6—lung cancer	1.05e-05	8.84e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—STAT3—lung cancer	1.04e-05	8.8e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NRAS—lung cancer	1.04e-05	8.78e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—AKT1—lung cancer	1.01e-05	8.52e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MAPK3—lung cancer	1.01e-05	8.52e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MAPK3—lung cancer	1.01e-05	8.49e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MAPK3—lung cancer	9.98e-06	8.41e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PIK3CA—lung cancer	9.95e-06	8.38e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MYC—lung cancer	9.83e-06	8.28e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MYC—lung cancer	9.8e-06	8.26e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MYC—lung cancer	9.7e-06	8.18e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—AKT1—lung cancer	9.68e-06	8.16e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—EGFR—lung cancer	9.61e-06	8.1e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—EGFR—lung cancer	9.58e-06	8.07e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—EGFR—lung cancer	9.49e-06	8e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—APOA1—lung cancer	9.12e-06	7.68e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—KRAS—lung cancer	9.08e-06	7.65e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—KRAS—lung cancer	9.05e-06	7.63e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—KRAS—lung cancer	8.96e-06	7.55e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PIK3CA—lung cancer	8.34e-06	7.03e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PIK3CG—lung cancer	8.32e-06	7.01e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PIK3CA—lung cancer	8.32e-06	7.01e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PIK3CA—lung cancer	8.24e-06	6.94e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—AKT1—lung cancer	8.13e-06	6.85e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TP53—lung cancer	8.07e-06	6.8e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TP53—lung cancer	8.05e-06	6.78e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TP53—lung cancer	7.97e-06	6.71e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—POMC—lung cancer	7.92e-06	6.68e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HRAS—lung cancer	7.72e-06	6.5e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CREBBP—lung cancer	7.72e-06	6.5e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HRAS—lung cancer	7.69e-06	6.48e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HRAS—lung cancer	7.62e-06	6.42e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL6—lung cancer	7.39e-06	6.23e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL6—lung cancer	7.36e-06	6.21e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PIK3CD—lung cancer	7.32e-06	6.17e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL6—lung cancer	7.29e-06	6.15e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ALB—lung cancer	7.22e-06	6.09e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—AKT1—lung cancer	6.82e-06	5.74e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—AKT1—lung cancer	6.79e-06	5.73e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—AKT1—lung cancer	6.73e-06	5.67e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PIK3CB—lung cancer	6.38e-06	5.37e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PTGS2—lung cancer	6.32e-06	5.33e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PTEN—lung cancer	5.51e-06	4.64e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—EP300—lung cancer	5.26e-06	4.43e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PIK3CA—lung cancer	3.89e-06	3.28e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—AKT1—lung cancer	3.18e-06	2.68e-05	CbGpPWpGaD
